Match tier
Likely match
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-08-16
Biography and Research Information
OverviewAI-generated summary
Àlex Soriano's research focuses on infectious diseases, antimicrobial resistance, and treatment strategies, particularly within adult populations. His work includes investigating novel antifungal agents, as demonstrated by his participation in the ReSTORE trial evaluating rezafungin versus caspofungin for candidemia and invasive candidiasis. He has also contributed to understanding the challenges and unmet needs in managing invasive candidiasis.
Soriano's research extends to bacterial infections, including a systematic review on the nephrotoxicity and neurotoxicity associated with polymyxin use and an observational study on the role of rifampin in staphylococcal periprosthetic joint infections. He has also been involved in guideline development for septic arthritis and has examined the immune response to SARS-CoV-2 vaccination in transplant recipients and the impact of SARS-CoV-2 infection in adults living with HIV. With a substantial publication record and high citation counts, Soriano's work contributes to the clinical management and understanding of complex infectious diseases.
Metrics
- h-index: 79
- Publications: 699
- Citations: 26,088
Selected Publications
-
Debridement, antimicrobial therapy, and implant retention (DAIR) as curative strategy for acute periprosthetic hip and knee infections: a position paper of the European Bone & Joint Infection Society (EBJIS) (2025)
-
Effectiveness and safety of cefiderocol treatment in patients with Gram-negative bacterial infections in Spain in the early access programme: results of the PERSEUS study (2025)
-
Prevalence and impact of multidrug-resistant bacteria in solid cancer patients with bloodstream infection: a 25-year trend analysis (2024)
-
Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018–2022 (2024)
-
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial (2024)
-
Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials (2023)
-
Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial (2023)
-
A second update on mapping the human genetic architecture of COVID-19 (2023)
-
Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review Panel (2023)
-
Carbapenem-Resistant <i>Acinetobacter</i> spp Infection in Critically Ill Patients With Limited Treatment Options: A Descriptive Study of Cefiderocol Therapy During the COVID-19 Pandemic (2023)
-
High Rate of Inappropriate Antibiotics in Patients with Hematologic Malignancies and Pseudomonas aeruginosa Bacteremia following International Guideline Recommendations (2023)
-
Invasive candidiasis: current clinical challenges and unmet needs in adult populations (2023)
-
Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study (2023)
-
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial (2023)
-
Real-Life Data on the Effectiveness and Safety of Cefiderocol in Severely Infected Patients: A Case Series (2023)
Collaboration Network
Top Collaborators
Carolina García‐Vidal
Hospital Clínic de Barcelona (ES)
17 shared publications
- Invasive candidiasis: current clinical challenges and unmet needs in adult populations
- Bacterial co-infection at hospital admission in patients with COVID-19
- Development of a severity of disease score and classification model by machine learning for hospitalized COVID-19 patients
- Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain
- Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19
Showing 5 of 17 shared publications
Pedro Puerta‐Alcalde
Hospital Clínic de Barcelona (ES)
15 shared publications
- Invasive candidiasis: current clinical challenges and unmet needs in adult populations
- Bacterial co-infection at hospital admission in patients with COVID-19
- Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study
- Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain
- Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19
Showing 5 of 15 shared publications
Laura Morata
Hospital Clínic de Barcelona (ES)
13 shared publications
- Bacterial co-infection at hospital admission in patients with COVID-19
- Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain
- Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19
- Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial
- Changing epidemiology of catheter-related bloodstream infections in neutropenic oncohematological patients
Showing 5 of 13 shared publications
Mariana Chumbita
Hospital Clínic de Barcelona (ES)
13 shared publications
- Bacterial co-infection at hospital admission in patients with COVID-19
- Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study
- Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain
- Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19
- Machine Learning to Assess the Risk of Multidrug-Resistant Gram-Negative Bacilli Infections in Febrile Neutropenic Hematological Patients
Showing 5 of 13 shared publications
Marta Bodro
Hospital Clínic de Barcelona (ES)
12 shared publications
- Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients
- Bacterial co-infection at hospital admission in patients with COVID-19
- Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain
- Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19
- A propensity score-matched analysis of mortality in solid organ transplant patients with COVID-19 compared to non-solid organ transplant patients
Showing 5 of 12 shared publications
Nicole García-Pouton
Hospital Clínic de Barcelona (ES)
10 shared publications
- Bacterial co-infection at hospital admission in patients with COVID-19
- Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain
- Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19
- Machine Learning to Assess the Risk of Multidrug-Resistant Gram-Negative Bacilli Infections in Febrile Neutropenic Hematological Patients
- Changing epidemiology of catheter-related bloodstream infections in neutropenic oncohematological patients
Showing 5 of 10 shared publications
Celia Cardozo
Hospital Clínic de Barcelona (ES)
10 shared publications
- Bacterial co-infection at hospital admission in patients with COVID-19
- Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain
- Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19
- Machine Learning to Assess the Risk of Multidrug-Resistant Gram-Negative Bacilli Infections in Febrile Neutropenic Hematological Patients
- Changing epidemiology of catheter-related bloodstream infections in neutropenic oncohematological patients
Showing 5 of 10 shared publications
Josep Mensa
Hospital Clínic de Barcelona (ES)
10 shared publications
- Bacterial co-infection at hospital admission in patients with COVID-19
- Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain
- Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19
- Machine Learning to Assess the Risk of Multidrug-Resistant Gram-Negative Bacilli Infections in Febrile Neutropenic Hematological Patients
- Mechanism of action of cefiderocol
Showing 5 of 10 shared publications
José Antonio Martínez
Hospital Clínic de Barcelona (ES)
8 shared publications
- Bacterial co-infection at hospital admission in patients with COVID-19
- Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain
- Machine Learning to Assess the Risk of Multidrug-Resistant Gram-Negative Bacilli Infections in Febrile Neutropenic Hematological Patients
- Changing epidemiology of catheter-related bloodstream infections in neutropenic oncohematological patients
- Real-life use of remdesivir in hospitalized patients with COVID-19
Showing 5 of 8 shared publications
Fernanda Meira
Hospital Clínic de Barcelona (ES)
7 shared publications
- Bacterial co-infection at hospital admission in patients with COVID-19
- Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain
- Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19
- Real-life use of remdesivir in hospitalized patients with COVID-19
- Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection
Showing 5 of 7 shared publications
Pedro Castro
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
6 shared publications
- Bacterial co-infection at hospital admission in patients with COVID-19
- Severe acute kidney injury in critically ill COVID-19 patients
- Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain
- Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19
- Real-life use of remdesivir in hospitalized patients with COVID-19
Showing 5 of 6 shared publications
Gerard Dueñas
Hospital Clínic de Barcelona (ES)
6 shared publications
- Bacterial co-infection at hospital admission in patients with COVID-19
- Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain
- Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19
- Real-life use of remdesivir in hospitalized patients with COVID-19
- Prolonged viral replication in patients with hematologic malignancies hospitalized with COVID-19
Showing 5 of 6 shared publications
Marta Hernández‐Meneses
Hospital Clínic de Barcelona (ES)
6 shared publications
- Bacterial co-infection at hospital admission in patients with COVID-19
- Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19
- Changing epidemiology of catheter-related bloodstream infections in neutropenic oncohematological patients
- Real-life use of remdesivir in hospitalized patients with COVID-19
- Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection
Showing 5 of 6 shared publications
Juan Ambrosioni
Hospital Clínic de Barcelona (ES)
6 shared publications
- Overview of SARS-CoV-2 infection in adults living with HIV
- Overview of SARS-CoV-2 infection in adults living with HIV
- Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19
- Real-life use of remdesivir in hospitalized patients with COVID-19
- Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection
Showing 5 of 6 shared publications
Sabina Herrera
Hospital Clínic de Barcelona (ES)
6 shared publications
- Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients
- Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19
- A propensity score-matched analysis of mortality in solid organ transplant patients with COVID-19 compared to non-solid organ transplant patients
- Disseminated Cryptococcus neoformans infection associated to COVID-19
- Prevalence and impact of multidrug-resistant bacteria in solid cancer patients with bloodstream infection: a 25-year trend analysis
Showing 5 of 6 shared publications
Similar Researchers
Based on overlapping research topics
Saloni Shirke
University of Arkansas – Fort Smith
Microbial infections and disease research
Pharmacological Effects and Toxicity Studies
Retrospective Studies
Jacob M. Keck
University of Arkansas for Medical Sciences
Antimicrobial Resistance in Bacteria
Microbial infections and disease research
Pharmacological Effects and Toxicity Studies
Jack Massey
University of Arkansas for Medical Sciences
Microbial infections and disease research
COVID-19 Clinical Research Studies
Retrospective Studies
Ryan K Dare
University of Arkansas for Medical Sciences
Antimicrobial Resistance in Bacteria
Microbial infections and disease research
Retrospective Studies
Holly Maples
University of Arkansas for Medical Sciences
Antimicrobial Resistance in Bacteria
Microbial infections and disease research
Pharmacological Effects and Toxicity Studies
Bina Laxmi Jayana
University of Arkansas for Medical Sciences
Antimicrobial Resistance in Bacteria
Microbial infections and disease research
Pharmacological Effects and Toxicity Studies